Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.08% Nasdaq Down0.11%

Harvard Bioscience Inc. (HBIO)

-NGM

5.16 May 23, 4:00PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income 2,370   3,812   19,015  
Operating Activities, Cash Flows Provided By or Used In
Depreciation4,258  4,418  4,006  
Adjustments To Net Income1,178  2,272  (9,491)
Changes In Accounts Receivables1,154  232  (1,088)
Changes In Liabilities(1,147)(2,308)966  
Changes In Inventories1,174  (1,705)(1,238)
Changes In Other Operating Activities(925)(73)123  
Total Cash Flow From Operating Activities 8,062   6,648   12,293  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,769)(1,506)(844)
Investments -   -   -  
Other Cash flows from Investing Activities(2,907)(5,692)(7,502)
Total Cash Flows From Investing Activities (4,676) (7,198) (8,346)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock2,287  567  (4,718)
Net Borrowings(3,350)(1,708)4,687  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities (1,063) (1,141) (31)
Effect Of Exchange Rate Changes442  (97)(800)
Change In Cash and Cash Equivalents 2,765   (1,788) 3,116  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.